Eiger BioPharmaceuticals, Inc. Business Finance Contracts & Agreements
38 Contracts & Agreements
- Assignment Agreements (1 contract)
- Investor Rights Agreements (1)
- Loan Agreements (9)
- Purchase Agreements (11)
- Release Agreements (1)
- Stock Agreements (6)
- Subscription Agreements (1)
- Underwriting Agreements (7)
- Warrant Agreements (1)
- Peginterferon Lambda Asset Purchase Agreement, dated August 1, 2024, by and between Eiger InnoTherapeutics, Inc. and Eiger BioPharmaceuticals, Inc (Filed With SEC on August 2, 2024)
- Lonafarnib Antiviral Asset Purchase Agreement, dated August 1, 2024, by and between Eiger InnoTherapeutics, Inc. and Eiger BioPharmaceuticals, Inc (Filed With SEC on August 2, 2024)
- Asset Purchase Agreement, dated June 21, 2024 (Filed With SEC on June 21, 2024)
- Asset Purchase Agreement, dated June 13, 2024 (Filed With SEC on June 14, 2024)
- Asset Purchase Agreement, dated March 31, 2024, by and between Sentynl Therapeutics, Inc. and Eiger BioPharmaceuticals, Inc (Filed With SEC on April 1, 2024)
- Common Stock Purchase Agreement (Filed With SEC on June 7, 2022)
- Loan and Security Agreement (Filed With SEC on June 7, 2022)
- Amendment No. 4 to Loan and Security Agreement, dated March 10, 2020, by and between Eiger BioPharmaceuticals, Inc. and Oxford Finance LLC (Filed With SEC on March 10, 2022)
- Amendment No. 6 to Loan and Security Agreement, dated October 6, 2021, by and between Eiger BioPharmaceuticals, Inc. and Oxford Finance LLC (Filed With SEC on November 4, 2021)
- Amendment No. 5 to Loan and Security Agreement, dated February 23, 2021, by and between Eiger BioPharmaceuticals, Inc. and Oxford Finance LLC (Filed With SEC on March 9, 2021)
- Asset Purchase Agreement, by and between Eiger BioPharmaceuticals, Inc. and AbbVie Inc., dated as of November 20, 2020 (Filed With SEC on March 9, 2021)
- Asset Purchase Agreement, dated September 25, 2015, by and between Eiger BioPharmaceuticals, Inc. and Tracey McLaughlin and Colleen Craig (Filed With SEC on March 9, 2021)
- Third Amendment to Loan and Security Agreement, dated March 5, 2019, by and between Eiger BioPharmaceuticals, Inc. and Oxford Finance LLC (Filed With SEC on May 9, 2019)
- Underwriting Agreement, dated April 17, 2019 (Filed With SEC on April 22, 2019)
- First Amendment to Loan and Security Agreement, dated August 24, 2017, by and between Eiger BioPharmaceuticals, Inc. and Oxford Finance LLC (Filed With SEC on March 14, 2019)
- Product Assignment 1, dated July 1, 2018, by and between Eiger BioPharmaceuticals, Inc. and RRD International, LLC (Filed With SEC on November 9, 2018)
- Common Stock Purchase Agreement, dated September 19, 2018, by and between Eiger BioPharmaceuticals, Inc. and RRD International, LLC (Filed With SEC on November 9, 2018)
- Underwriting Agreement, dated as of October 23, 2018, by and between Eiger BioPharmaceuticals, Inc. and BTIG, LLC (Filed With SEC on October 23, 2018)
- Second Amendment to Loan and Security Agreement, dated May 11, 2018, by and between Eiger BioPharmaceuticals, Inc. and Oxford Finance LLC (Filed With SEC on August 10, 2018)
- Purchase Agreement, dated as of May 24, 2018, by and between Eiger BioPharmaceuticals, Inc. and Piper Jaffray & Co (Filed With SEC on May 25, 2018)
- Underwriting Agreement, dated October 27, 2017, by and between the Company and the Underwriter (Filed With SEC on October 30, 2017)
- LOAN AND SECURITY AGREEMENT (Filed With SEC on March 23, 2017)
- Eiger BioPharmaceuticals, Inc. 2013 Employee Stock Purchase Plan Adopted by the Board of Directors: September 3, 2013 Approved by the Stockholders: October 10, 2013 Amended by the... (Filed With SEC on November 8, 2016)
- 1,250,000 EIGERBIOPHARMACEUTICALS, INC. UNDERWRITING AGREEMENT (Filed With SEC on August 19, 2016)
- ASSET PURCHASE AGREEMENT among: EIGERBIOPHARMACEUTICALS, INC. a Delaware corporation; and EICCOSE, LLC, a Delaware limited liability company Dated as ofOctober 29, 2015 ASSET... (Filed With SEC on December 14, 2015)
- ASSET PURCHASE AGREEMENT among: EIGER BIOPHARMACEUTICALS,INC., a Delaware corporation; and TRACEY MCLAUGHLIN ANDCOLLEEN CRAIG Dated as of September 25, 2015 ASSET PURCHASE... (Filed With SEC on December 14, 2015)
- ASSET PURCHASE AGREEMENT (Filed With SEC on December 14, 2015)
- SUBSCRIPTION AGREEMENT (Filed With SEC on December 14, 2015)
- EXHIBIT A RELEASE AGREEMENT (Filed With SEC on August 11, 2015)
- AMENDMENT NO. 1 TO LOAN AND SECURITY AGREEMENT (Filed With SEC on March 31, 2015)
- CELLADON CORPORATION [ l ] Shares of Common Stock (par value $0.001 per share) Underwriting Agreement (Filed With SEC on August 7, 2014)
- CELLADON CORPORATION Shares of Common Stock (par value $0.0001 per share) Underwriting Agreement (Filed With SEC on January 22, 2014)
- CELLADON CORPORATION 2013 EMPLOYEE STOCK PURCHASE PLAN ADOPTED BY THE BOARD OF DIRECTORS:SEPTEMBER 3, 2013 APPROVED BY THE STOCKHOLDERS:OCTOBER 10, 2013 (Filed With SEC on November 1, 2013)
- WARRANT TOPURCHASE SHARES OF SERIES A-1 PREFERRED STOCK of CELLADON CORPORATION INCORPORATED UNDER THE LAWS OF THE STATE OF DELAWARE (Filed With SEC on October 29, 2013)
- CELLADON CORPORATION 2013 EMPLOYEE STOCK PURCHASE PLAN ADOPTED BY THE BOARD OF DIRECTORS:SEPTEMBER 3, 2013 APPROVED BY THE STOCKHOLDERS:OCTOBER 10, 2013 (Filed With SEC on October 11, 2013)
- CELLADON CORPORATION 2001 STOCK OPTION PLAN (Filed With SEC on October 11, 2013)
- CELLADON CORPORATION AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT (Filed With SEC on October 11, 2013)
- CELLADON CORPORATION Shares of Common Stock (par value $0.0001 per share) Underwriting Agreement (Filed With SEC on October 11, 2013)
